Cell Therapy Media Market Size, Share, Trends By 2035

By Author: kylie
Total Articles: 81
Comment this article

Roots Analysis is pleased to announce the publication of its recent study, titled, “Cell Therapy Manufacturing Market (5th Edition), 2022-2035.”

The report features an extensive study of the current market landscape and future opportunities associated with cell therapy manufacturing, along with information on both contract manufacturers, as well as developers having in-house production capabilities, offering in-depth analyses of the various business entities engaged in this domain, across key global regions. Amongst other elements, the report includes:
 A general overview of cell therapies, along with information on the key challenges and factors influencing the cell therapy manufacturing market, along with details on the automation tools and technologies being utilized for improving manufacturing processes and the future prospects in this domain.
 A detailed review of the overall landscape of players engaged in the manufacturing of cell-based therapies, along with information on type of cell manufactured, source of cell, scale of operation, purpose of production, manufacturing capabilities / services ...
... offered, as well as location of headquarters and their respective manufacturing facilities.
 A discussion on cell therapy manufacturing regulations across various geographies.
 An overview of the various roadmaps published by different agencies across the globe in order to provide strategies to advance cell therapy manufacturing processes.
 An elaborate discussion on the role of automation technologies in improving the current manufacturing methods.
 Elaborate profiles of key players (industry and non-industry) that offer contract manufacturing services for cell-based therapies.
 A discussion on the role of non-profit organizations, featuring a list of organizations that are actively involved in the development and production of cell-based therapies
 An analysis of completed, ongoing and planned clinical trials evaluating the efficacy of cell therapies for the treatment of various disease indications
 An analysis of the recent partnerships focused on the manufacturing of cell-based therapies, which have been established during the period 2016-2022.
 An analysis of the various expansion initiatives undertaken by service providers engaged in this domain in order to augment their respective cell therapy manufacturing capabilities.
 A review of the various cell therapy manufacturing initiatives undertaken by big pharma players engaged in this domain.
 An estimate of the overall, installed capacity for the manufacturing of cell-based therapies.
 Informed estimates of the annual commercial and clinical demand for cell therapies (in terms of number of patients).
 A detailed analysis of various factors that are likely to influence the price of cell-based therapies.
 A qualitative analysis, highlighting the various factors that need to be taken into consideration by cell therapy developers, while deciding whether to manufacture their respective products in-house or engage the services of a CMO.
 An in-depth analysis of cell therapy manufacturers using three versatile representations.
 A discussion on affiliated trends, key drivers and challenges, which are likely to impact the industry's evolution, under an elaborate SWOT framework.
 Insights generated in a market-wide survey, featuring inputs solicited from experts who are directly / indirectly involved in the development and / or manufacturing of cell-based therapies.
 A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
 Type of Cell Therapy
 T cell therapies
 Dendritic cell therapies
 NK cell therapies
 Stem cell therapies
 Source of Cell
 Autologous
 Allogeneic
 Scale of Operation
 Clinical
 Commercial
 Purpose of Manufacturing
 In-house Manufacturing
 Contract Manufacturing
 Geographical Regions
 North America
 Europe
 Asia Pacific
 Rest of the World

Key companies / organizations covered in the report
 AGC Biologics
 BioNTech Innovative Manufacturing Services
 Cell and Gene Therapy Catapult
 Cell Therapies
 Center for Cell and Gene Therapy, Baylor College of Medicine
 Center for Cell Manufacturing Ireland, National University of Ireland
 Charles River Laboratories
 Clinical Cell and Vaccine Production Facility, University of Pennsylvania
 FUJIFILM Cellular Dynamics
 Guy’s and St. Thomas GMP Facility, Guy’s Hospital
 KBI Biopharma
 Laboratory for Cell and Gene Medicine, Stanford University
 Lonza
 MEDINET
 Minaris Regenerative Medicine
 Molecular and Cellular Therapeutics, University of Minnesota
 Newcastle Cellular Therapies Facility, Newcastle University
 Nikon CeLL innovation
 Rayne Cell Therapy Suite, King’s College London
 RoslinCT
 Scottish National Blood Transfusion Service, Scottish Centre of Regenerative Medicine
 Sydney Cell and Gene Therapy
 Thermofisher Scientific
 WuXi AppTec

To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/view_document/cell-therapy-manufacturing/285.html

You may also be interested in the following titles:
Buffer Preparation Market

Nanoparticle Formulation Market

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com